J. Oliver

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

E. Dmitrovsky, M. Kris, V. Rusch, 1995, Cancer research.

Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants

P. Tarpey, D. Baralle, J. Tolmie, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Scott A. Prentice, Jessica M. Powell, Sharon L. Burns, 2019, The Lancet.